CCDC179: A Drug Target / Disease Biomarker (G100500938)

Target Name: CCDC179

NCBI ID: G100500938

CCDC179

Other Name(s): CC179_HUMAN | Coiled-coil domain-containing protein 179 | coiled-coil domain containing 179 | Coiled-coil domain containing 179

CCDC179: A Drug Target / Disease Biomarker

CCDC179 is a protein that is expressed in various tissues throughout the body. It is a member of the carcinoembryonic antigen (CEA) family, which is a group of glycoproteins that are expressed in a variety of tissues, including cancer cells. CCDC179 is of particular interest as a potential drug target due to its involvement in cancer progression and its over-expression in various types of cancer.

CDC179 is a transmembrane protein that is expressed in various tissues, including the brain, heart, liver, and gastrointestinal tract. It is involved in several cellular processes, including cell adhesion, migration, and invasion. CCDC179 is also involved in the regulation of cell growth and apoptosis, which are processes that are critical for cancer progression.

One of the most significant ways that CCDC179 is involved in cancer progression is its role in the development of cancer stem cells (CSCs). CSCs are a subset of cancer cells that have the ability to generate new, cancerous tumors. CCDC179 has been shown to be involved in the development and maintenance of CSCs.

Another way that CCDC179 is involved in cancer progression is its role in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to cancer cells. CCDC179 has been shown to be involved in the regulation of angiogenesis, which can contribute to the development of new blood vessels that supply these tumors with the oxygen and nutrients they need to grow and multiply.

In addition to its role in cancer progression, CCDC179 has also been shown to be involved in the regulation of cellular signaling pathways. For example, CCDC179 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is a pathway that is involved in the regulation of cell growth, apoptosis, and inflammation.

Due to its involvement in cancer progression and its regulation of cellular signaling pathways, CCDC179 is of particular interest as a potential drug target. Researchers are currently working to develop drugs that can specifically target CCDC179 and inhibit its activity. These drugs may be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, CCDC179 is a protein that is expressed in various tissues throughout the body and is involved in several cellular processes, including cell adhesion, migration, and invasion. It is also involved in the regulation of cell growth and apoptosis and has been shown to be involved in the development and maintenance of cancer stem cells. As a result, CCDC179 is of particular interest as a potential drug target for the treatment of a variety of diseases.

Protein Name: Coiled-coil Domain Containing 179

The "CCDC179 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC179 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets